Catalyst Pharmaceuticals, Inc. Information

Catalyst Pharmaceuticals, Inc. is a wholly owned subsidiary of Angelini Pharma. Catalyst is a biopharmaceutical company committed to improving the lives of patients with rare diseases. With a proven track record of bringing life-changing treatments to the market, we focus on in-licensing, commercializing, and developing innovative therapies. Guided by our deep commitment to patient care, we prioritize accessibility, ensuring patients receive the care they need through a comprehensive suite of support services designed to provide seamless access and ongoing assistance. Catalyst maintains a well-established U.S. presence while actively seeking to expand its global commercial footprint through strategic partnerships. Catalyst is headquartered in Coral Gables, FL., and was recognized on the Forbes 2025 list as one of America's most successful small-cap companies. For more information, please visit Catalyst's website at www.catalystpharma.com. View our Privacy Policy: https://catalystpharma.com/privacy-policy/ View our Social Media Guidelines: https://catalystpharma.com/social-media-guidelines/